Hallucination modality and pathology in Alzheimer's disease and Lewy body disease

INTRODUCTION: Visual hallucinations occur in clinically diagnosed Alzheimer’s disease (AD), in which Lewy co-pathology is common. Associations of hallucination modality with Lewy pathology distribution and Alzheimer co-pathology were examined at autopsy. METHODS: National Alzheimer’s Coordinating Center data were analyzed from 4,855 autopsied participants with clinical AD and 530 with clinical Lewy body disease (LBD). Hallucinations at the first visit with cognitive impairment were classified as visual only, combined visual and auditory, auditory only or absent. Primary logistic models were adjusted for age, sex and data set version. RESULTS: In clinical AD, visual-only and combined hallucinations were associated with neocortical versus absent Lewy pathology (odds ratio [OR] 2.78, 95% confidence interval [CI] 1.84–4.20; and 2.90, 1.71–4.93) and neocortical versus limbic pathology (2.30, 1.39–3.82; and 3.44, 1.64–7.21). Visual-only hallucinations in AD were associated with Braak stage 5–6 (1.86, 1.19–2.89). Combined hallucinations in LBD were nominally associated with intermediate/high Alzheimer disease neuropathologic change (3.19, 1.28–7.98), without an established difference from visual-only hallucinations (P = .066). In LBD, visual-only hallucinations recorded at any visit were associated with neocortical pathology (3.02, 1.67–5.45). Newly recorded rapid eye movement sleep behavior disorder symptoms, fluctuations or parkinsonism at about 2 years were associated with neocortical pathology in clinical AD participants without these features at index (2.55, 1.69–3.83). DISCUSSION: Hallucinations in clinical AD and LBD were associated with both neocortical Lewy distribution and Alzheimer pathology. The findings support considering both pathologies and reassessing core Lewy features during follow-up, while individual diagnostic utility requires validation. Keywords: Alzheimer’s disease; Lewy body disease; dementia with Lewy bodies; Lewy co-pathology; neuropathology; visual hallucinations; auditory hallucinations; National Alzheimer’s Coordinating Center

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-13
DOI
https://doi.org/10.5281/zenodo.24199677
Primary Topic
Hallucinations in medical conditions
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Hallucination modality and pathology in Alzheimer's disease and Lewy body disease

Andreas Albert Braun
4 links
Zenodo (CERN European Organization for Nuclear Research)
Hallucinations in medical conditions
preprint

Hallucination modality and pathology in Alzheimer's disease and Lewy body disease

Andreas Albert Braun
preprint en

Abstract

INTRODUCTION: Visual hallucinations occur in clinically diagnosed Alzheimer’s disease (AD), in which Lewy co-pathology is common. Associations of hallucination modality with Lewy pathology distribution and Alzheimer co-pathology were examined at autopsy. METHODS: National Alzheimer’s Coordinating Center data were analyzed from 4,855 autopsied participants with clinical AD and 530 with clinical Lewy body disease (LBD). Hallucinations at the first visit with cognitive impairment were classified as visual only, combined visual and auditory, auditory only or absent. Primary logistic models were adjusted for age, sex and data set version. RESULTS: In clinical AD, visual-only and combined hallucinations were associated with neocortical versus absent Lewy pathology (odds ratio [OR] 2.78, 95% confidence interval [CI] 1.84–4.20; and 2.90, 1.71–4.93) and neocortical versus limbic pathology (2.30, 1.39–3.82; and 3.44, 1.64–7.21). Visual-only hallucinations in AD were associated with Braak stage 5–6 (1.86, 1.19–2.89). Combined hallucinations in LBD were nominally associated with intermediate/high Alzheimer disease neuropathologic change (3.19, 1.28–7.98), without an established difference from visual-only hallucinations (P = .066). In LBD, visual-only hallucinations recorded at any visit were associated with neocortical pathology (3.02, 1.67–5.45). Newly recorded rapid eye movement sleep behavior disorder symptoms, fluctuations or parkinsonism at about 2 years were associated with neocortical pathology in clinical AD participants without these features at index (2.55, 1.69–3.83). DISCUSSION: Hallucinations in clinical AD and LBD were associated with both neocortical Lewy distribution and Alzheimer pathology. The findings support considering both pathologies and reassessing core Lewy features during follow-up, while individual diagnostic utility requires validation. Keywords: Alzheimer’s disease; Lewy body disease; dementia with Lewy bodies; Lewy co-pathology; neuropathology; visual hallucinations; auditory hallucinations; National Alzheimer’s Coordinating Center

Zenodo (CERN European Organization for Nuclear Research)
University Hospital of Geneva (CH)
Good health and well-being
Hallucinations in medical conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon